# Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

> **NCT00309972** · PHASE3 · COMPLETED · sponsor: **University College, London** · enrollment: 130 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Control arm (SEQ):
- **DRUG:** Experimental arm (CON):

## Key facts

- **NCT ID:** NCT00309972
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2011-02
- **Final completion:** 2012-02
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309972, "Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00309972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*